Compare RDY & AIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | AIN |
|---|---|---|
| Founded | 1984 | 1895 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Textiles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 1.7B |
| IPO Year | N/A | 1987 |
| Metric | RDY | AIN |
|---|---|---|
| Price | $14.00 | $51.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | $16.90 | ★ $64.25 |
| AVG Volume (30 Days) | ★ 954.3K | 470.3K |
| Earning Date | 01-22-2026 | 11-05-2025 |
| Dividend Yield | 0.51% | ★ 2.15% |
| EPS Growth | ★ 9.95 | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $3,851,623,984.00 | $1,148,512,000.00 |
| Revenue This Year | $6.16 | N/A |
| Revenue Next Year | $2.57 | N/A |
| P/E Ratio | $17.82 | ★ N/A |
| Revenue Growth | ★ 14.10 | N/A |
| 52 Week Low | $12.26 | $41.15 |
| 52 Week High | $16.17 | $83.65 |
| Indicator | RDY | AIN |
|---|---|---|
| Relative Strength Index (RSI) | 50.98 | 58.66 |
| Support Level | $13.64 | $49.13 |
| Resistance Level | $14.21 | $50.84 |
| Average True Range (ATR) | 0.17 | 1.45 |
| MACD | 0.01 | 1.00 |
| Stochastic Oscillator | 64.04 | 77.35 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.